{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:57:04Z","timestamp":1695707824981},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1378\/chest.118.5.1516","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"1516-1517","source":"Crossref","is-referenced-by-count":8,"title":["The Age-Adjusted Mortality Rate From Primary Pulmonary Hypertension, in Age Range 20 to 54 Years, Did Not Increase During the Years of Peak \u201cPhen\/Fen\u201d Use"],"prefix":"10.1016","volume":"118","author":[{"given":"Richard B.","family":"Rothman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.118.5.1516_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1378\/chest.117.3.796","article-title":"Mortality from primary pulmonary hypertension in the United States, 1979\u20131996","volume":"117","author":"Lilienfeld","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.118.5.1516_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group (comment)","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.118.5.1516_bib3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/clpt.1992.76","article-title":"Long-term weight control study: conclusions","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl","key":"10.1378\/chest.118.5.1516_bib4","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1378\/chest.114.3_Supplement.195S","article-title":"Primary pulmonary hypertension associated with the use of fenfluramine derivatives","volume":"114","author":"Simonneau","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.118.5.1516_bib5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.117.3.870","article-title":"Anorexigens and pulmonary hypertension in the United States: results from the Surveillance of North American Pulmonary Hypertension","volume":"117","author":"Rich","year":"2000","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215512439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215512439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:22:42Z","timestamp":1553113362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215512439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S0012369215512439"],"URL":"https:\/\/doi.org\/10.1378\/chest.118.5.1516","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}